Literature DB >> 27097544

Diagnostic value of GATA-3 in cytological identification of parathyroid tissues.

Nami Takada1, Mitsuyoshi Hirokawa, Ayana Suzuki, Miyoko Higuchi, Seiji Kuma, Akira Miyauchi.   

Abstract

Parathyroid and thyroid lesions appear morphologically similar in cytological smears, and their differentiation can be difficult. The purpose of this study was to determine the diagnostic value of T-cell-specific transcription factor GATA-3 as a marker of parathyroid differentiation in cytology specimens, and to examine the utility of liquid-based cytology (LBC). Cytology smears obtained from surgically removed parathyroid and thyroid specimens, including 15 normal parathyroid glands, 12 cases of parathyroid hyperplasia, 55 parathyroid adenomas, 2 follicular thyroid adenomas, and 3 papillary thyroid carcinomas, were examined by immunocytochemistry using antibodies against GATA-3, parathyroid hormone (PTH), chromogranin A, and thyroid transcription factor 1 (TTF-1). All normal and hyperplastic parathyroids and 98.2% of parathyroid adenomas were positive for GATA-3, while 33.3%, 66.7%, and 60.0% of them, respectively, were positive for PTH. The positive rates for chromogranin A among normal parathyroids (80.0%) and parathyroid adenomas (87.3%) were lower than those for GATA-3. At the same time, all thyroid-derived tumours were positive for TTF-1 and negative for GATA-3, PTH, and chromogranin A. LBC smears of 35 parathyroid lesions indicated that the positive rates for GATA-3, PTH, and chromogranin A were 97.1 %, 97.1%, and 100%, respectively, while in conventional smears, those for PTH (25.5%) and chromogranin A (78.7%) were significantly lower (p < 0.01). Our results suggest that GATA-3 is a more reliable biomarker than PTH or chromogranin A in differentiating parathyroid from thyroid lesions in cytology smears and that LBC is useful in detecting cytoplasmic antigens such as PTH and chromogranin A.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27097544     DOI: 10.1507/endocrj.EJ15-0700

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

1.  Giant parathyroid tumours in primary hyperparathyroidism: a systematic review.

Authors:  Ho Kiu Grace Wong; Kate Shipman; Kimberley Allan; Andrew Ghabbour; Farzad Borumandi
Journal:  Langenbecks Arch Surg       Date:  2022-01-18       Impact factor: 3.445

Review 2.  Immunohistochemical Biomarkers in Thyroid Pathology.

Authors:  Zubair Baloch; Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

3.  Parathyroid carcinoma detected within the thyroid.

Authors:  Koki Otake; Yuichi Kondo; Kenji Tsukamoto; Tomomi Kurahashi; Katsunori Sato; Hiroaki Ozawa; Kazuki Yokoi; Minemori Watanabe
Journal:  Nagoya J Med Sci       Date:  2021-05       Impact factor: 1.131

4.  The input of GATA-3 in the identification of parathyroid carcinoma diagnosis: Case report with review of literature.

Authors:  Zainab Lajmi; Ahlem Bdioui; Ahlem Bchir; Emene Ben Ammou; Nabiha Missaoui; Sihem Hmissa
Journal:  Ann Med Surg (Lond)       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.